SER
Serina Therapeutics, Inc. · Healthcare · Market cap $56.4M
Insiders bought $78K net in the last 90 days ·0 sellers, 4 buyers· latest Form 4 filed Jul 9, 2026
Insider Buying
$78K
reported purchases (SEC code P)
Insider Selling
$501K
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Jul 9, 2026
Brannan Stephen K.
Serina Therapeutics, Inc. (SER) has 34 SEC Form 4 filings (71 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 9, 2026.
Inside the rolling window, 5 insiders at Serina Therapeutics, Inc. reported 7 open-market purchases totaling $78K and 29 open-market sales totaling $501K. The most active filer is Chief Scientific Officer Moreadith Randall with 29 filings. Insiders have net sold $117K over the trailing 6 months. The most recent open-market filing is a purchase of 1,000 shares by Director Brannan Stephen K., dated Jul 7, 2026, worth $2K.
- Industry:Biotechnology
- CEO:Steven A. Ledger
- Employees:16
- HQ:Huntsville, AL, US
- IPO:2018-11-28
| Source | |||||||
|---|---|---|---|---|---|---|---|
Brannan Stephen K.First filing | Director | Purchase | 1,000 | $2K | Jul 9 | +0.9% | SEC ↗ |
Venkatesan JayFirst filing | Director | Purchase | 589 | $1K | Jun 22 | +17.5% | SEC ↗ |
| Director | Purchase | 5,100 | $9K | Jun 15 | +16.2% | SEC ↗ | |
| Director | Purchase | 5,000 | $9K | Jun 15 | +16.2% | SEC ↗ | |
WILSON KAREN JFirst filing | Director | Purchase | 10,000 | $18K | May 26 | +15.6% | SEC ↗ |
WILSON KAREN JFirst filing | Director | Purchase | 10,000 | $19K | May 26 | +15.6% | SEC ↗ |
Marshall Richard PeterFirst filing | Director | Purchase | 12,183 | $20K | May 22 | +12.1% | SEC ↗ |
| Chief Scientific Officer | Sale | 6,500 | $19K | Mar 24 | -8.6% | SEC ↗ | |
| Chief Scientific Officer | Sale | 39,000 | $98K | Mar 20 | -12.6% | SEC ↗ | |
| Chief Scientific Officer | Sale | 6,500 | $20K | Feb 3 | -19.6% | SEC ↗ | |
| Chief Scientific Officer | Sale | 6,500 | $23K | Jan 29 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 2,500 | $7K | Jan 23 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 2,000 | $6K | Jan 21 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 2,000 | $6K | Jan 21 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 5,416 | $14K | Jan 14 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,084 | $3K | Jan 14 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 13,000 | $35K | Jan 9 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 4,100 | $11K | Dec 29 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 5,673 | $15K | Dec 23 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 3,227 | $10K | Dec 17 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,700 | $6K | Dec 16 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 3,555 | $12K | Dec 12 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 600 | $2K | Dec 11 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 645 | $2K | Dec 11 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,500 | $6K | Dec 4 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does SER have?
Serina Therapeutics, Inc. (SER) has 34 SEC Form 4 filings (71 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Jul 9, 2026.
When was the most recent SEC Form 4 filing for SER?
The most recent Form 4 filing for SER on Tracefour is dated Jul 9, 2026.
Who is the most active insider at SER?
The most active SEC Form 4 filer at SER in the rolling window is Chief Scientific Officer Moreadith Randall, with 29 filings.
What is the net insider flow at SER over the last 6 months?
Over the trailing 180 days, insiders at SER have net sold $117K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at SER in the current window?
Inside the rolling window, insiders at SER bought $78K and sold $501K based on SEC Form 4 filings.
Can I get alerts for SER insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Serina Therapeutics, Inc. (SER). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Serina Therapeutics, Inc. is in the Healthcare sector.